KNSA vs. AGX

Last updated Jun 20, 2026

KNSA (Kiniksa Pharmaceuticals, Ltd.) and AGX (Argan, Inc.) are both stocks. KNSA operates in Biotechnology (Healthcare), while AGX operates in Engineering & Construction (Industrials). Over the past 5 years, KNSA returned 29.69%/yr vs 77.59%/yr for AGX. At a 0.16 correlation, their price movements are largely independent.

Performance

KNSA vs. AGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kiniksa Pharmaceuticals, Ltd. (KNSA) and Argan, Inc. (AGX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, KNSA achieves a 33.60% return, which is significantly lower than AGX's 136.30% return.

KNSA

• 1D: 1.66%
• 1M: 3.51%
• YTD: 33.60%
• 6M: 27.60%
• 1Y: 93.78%
• 3Y*: 52.43%
• 5Y*: 29.69%
• 10Y*: —

AGX

• 1D: 2.69%
• 1M: 12.57%
• YTD: 136.30%
• 6M: 127.40%
• 1Y: 265.42%
• 3Y*: 168.60%
• 5Y*: 77.59%
• 10Y*: 36.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

KNSA vs. AGX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
KNSA Kiniksa Pharmaceuticals, Ltd.	33.60%	108.54%	12.77%	17.09%	27.27%	-33.39%	59.76%	-60.63%	14.89%
AGX Argan, Inc.	136.30%	130.61%	198.31%	30.24%	-2.01%	-11.64%	19.15%	8.62%	-0.51%

Correlation

The correlation between KNSA and AGX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since May 24, 2018	0.16

Fundamentals

Market Cap KNSA : $4.54B AGX : $10.49B
EPS KNSA : $0.92 AGX : $11.38
PE Ratio KNSA : 59.85 AGX : 64.90
PEG Ratio KNSA : 0.58 AGX : 1.18
PS Ratio KNSA : 5.80 AGX : 10.05
PB Ratio KNSA : 7.50 AGX : 22.15
Total Revenue (TTM) KNSA : $754.05M AGX : $1.04B
Gross Profit (TTM) KNSA : $294.06M AGX : $217.93M
EBITDA (TTM) KNSA : $101.06M AGX : $163.99M

Return for Risk

KNSA vs. AGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KNSA

KNSA Risk / Return Rank: 92
KNSA Sharpe Ratio Rank: 91
KNSA Sortino Ratio Rank: 91
KNSA Omega Ratio Rank: 90
KNSA Calmar Ratio Rank: 91
KNSA Martin Ratio Rank: 94

AGX

AGX Risk / Return Rank: 96
AGX Sharpe Ratio Rank: 97
AGX Sortino Ratio Rank: 94
AGX Omega Ratio Rank: 93
AGX Calmar Ratio Rank: 98
AGX Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KNSA vs. AGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	KNSA	AGX	Difference
Sharpe ratio: Return per unit of total volatility	2.27	3.53	-1.26
Sortino ratio: Return per unit of downside risk	3.31	3.79	-0.48
Omega ratio: Gain probability vs. loss probability	1.41	1.48	-0.07
Calmar ratio: Return relative to maximum drawdown	4.63	10.51	-5.87
Martin ratio: Return relative to average drawdown	16.35	29.94	-13.59

KNSA vs. AGX - Sharpe Ratio Comparison

The current KNSA Sharpe Ratio is 2.27, which is lower than the AGX Sharpe Ratio of 3.53. The chart below compares the historical Sharpe Ratios of KNSA and AGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

KNSA vs. AGX - Drawdown Comparison

The maximum KNSA drawdown since its inception was -83.06%, smaller than the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for KNSA and AGX.

Drawdown Indicators

	KNSA	AGX	Difference
Max Drawdown Largest peak-to-trough decline	-83.06%	-94.37%	+11.31%
Max Drawdown (1Y) Largest decline over 1 year	-21.12%	-24.96%	+3.84%
Max Drawdown (3Y) Largest decline over 3 years	-34.14%	-43.75%	+9.61%
Max Drawdown (5Y) Largest decline over 5 years	-53.17%	-43.75%	-9.42%
Max Drawdown (10Y) Largest decline over 10 years	—	-54.61%	—
Current Drawdown Current decline from peak	-7.35%	-0.28%	-7.07%
Average Drawdown Average peak-to-trough decline	-40.60%	-48.31%	+7.71%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.97%	8.74%	-2.77%

Volatility

KNSA vs. AGX - Volatility Comparison

The current volatility for Kiniksa Pharmaceuticals, Ltd. (KNSA) is 10.40%, while Argan, Inc. (AGX) has a volatility of 17.73%. This indicates that KNSA experiences smaller price fluctuations and is considered to be less risky than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KNSA	AGX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.40%	17.73%	-7.33%
Volatility (6M) Calculated over the trailing 6-month period	34.02%	54.86%	-20.84%
Volatility (1Y) Calculated over the trailing 1-year period	43.03%	74.38%	-31.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.48%	51.09%	+2.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.93%	45.94%	+17.99%

Dividends

KNSA vs. AGX - Dividend Comparison

KNSA has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.25%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AGX Argan, Inc.	0.25%	0.52%	0.93%	2.24%	2.71%	1.94%	7.31%	2.49%	1.98%	4.44%	1.42%	2.16%
KNSA Kiniksa Pharmaceuticals, Ltd.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

KNSA vs. AGX - Profitability Comparison

The chart below illustrates the profitability comparison between Kiniksa Pharmaceuticals, Ltd. and Argan, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.

AGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 61.11M and revenue of 290.95M. Therefore, the gross margin over that period was 21.0%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.

AGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 45.40M and revenue of 290.95M, resulting in an operating margin of 15.6%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.

AGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 46.06M and revenue of 290.95M, resulting in a net margin of 15.8%.

Frequently Asked Questions

Can I hold both KNSA and AGX in my portfolio?

KNSA and AGX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, KNSA or AGX?

AGX has higher volatility (17.73%) compared to KNSA (10.40%). In terms of maximum drawdown, KNSA dropped -83.06% vs AGX's -94.37%.

Which has better risk-adjusted returns?

AGX currently has the higher Sharpe Ratio (3.53 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.